MAIA Cumulative medicines toolkit
As part of the MAIA consortium, CATAG has developed the MAIA Cumulative medicines toolkit to assist Medicines and Therapeutics Committees…
Understanding medicines access programs
This document is to assist healthcare professionals explain the complex area of Medicine Access Programs (MAPs) to consumers. It outlines the…
Facilitating the translation of evidence into best practice: Optimising the pharmacological management of inflammatory arthritis
CATAG has developed this document to facilitate and support the translation of best available evidence into practice for the management…
Getting it Right for Medicines Stewardship
These Guiding Principles for Medicines Stewardship Programs will assist health service organisations to develop and implement medicines stewardship programs. The…
Position statement for the use of complementary and alternative medicines
This position statement provides guidance on the management and use of complementary and alternative medicines (CAM), which are not listed…
Managing medication samples
Guiding Principles on using medication samples in Australian public hospitals. This document, updated in 2022, provides guidance to Medicines and…
Navigating high-cost medicines
These Guiding Principles provide a principles based high level framework outlining national objectives to assist medicines governance committees, including Medicines…
Therapeutic drug monitoring in inflammatory bowel disease
CATAG has developed this document to facilitate and support the translation of best available evidence into practice for the management…
Biologics and biosimilars best practice
These Guiding Principles provide a national approach to the governance of biologics and their biosimilars. They assist those responsible for…
Optimising My Health Record utilisation
The Position statement supports the use of the My Health Record (MHR) in Australian public hospitals as a tool to…